5 Most Promising Future Stocks To Buy According To Hedge Funds

4. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Number of Hedge Fund Investors During Q3 2023: 40

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is an Ireland based biotechnology company that develops treatments for sleep disorders and other ailments. Its shares are rated Strong Buy on average and analysts have set an average share price target of $191.18.

During this year’s September quarter, 40 out of the 910 hedge funds covered by Insider Monkey’s research were the firm’s investors. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)’s largest hedge fund shareholder is Robert Pohly’s Samlyn Capital as it owns $175 million worth of shares.

Follow Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)